- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Pyxis Oncology advances to $152m series B
The cancer treatment developer, co-founded by researchers from University of Chicago, has secured funding in a round co-led by Arix Bioscience and RTW Investments.
Apr 1, 2021Omega sanctions $126m series C round
The developer of epigenetic medicine, based on Whitehead Institute research, pulled in funding through a round led by founding investor Flagship Pioneering.
Apr 1, 2021Immune-Onc gets $73m funding influx
The cancer therapy developer, which is commercialising research from University of Texas, has raised series B1 and B2 financing.
Apr 1, 2021Daily deal net: March 31, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Mar 31, 2021Coursera graduates to public markets in $519m IPO
The online learning platform developer spun out of Stanford University priced its shares at the top of their range.
Mar 31, 2021Amgen rides to Rodeo acquisition
CWRU and UTMC-linked Rodeo Therapeutics is set to be acquired by Amgen for $55m in upfront and up to $666m in milestone payments.
Mar 31, 2021Entrada enters series B stage
Ohio State University spinout Entrada Therapeutics has pocketed $116m in a series B round.
Mar 31, 2021OncoResponse raises $40.6m series C
MD Anderson Cancer Center spinout OncoResponse has added $40.6m to its coffers thanks to series C investors including Arch Venture Partners.
Mar 31, 2021Achilles ascends to Nasdaq
Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.
Mar 31, 2021OnQuality orchestrates $20m series A-plus
Cash Capital has returned for OnQuality Pharmaceuticals’s latest round, having already participated in a $15m series A in 2019.
Mar 31, 2021Altaroad finds way to $11.7m
Satt Paris-Saclay’s portfolio company Altaroad has raised $11.7m in funding.
Mar 31, 2021Fortis fortifies with $40m
Existing backers Lilly Asia Ventures and Osage University Partners helped the UCSF cancer therapy spinout close its series A round.
Mar 31, 2021Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
